Patent · US Expired

Condensed thienopyrimidines with phosphodiesterase-v inhibiting action

US6495557B1 · kind B1 · utility

2Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2001
Grant dateDec 17, 2002
Priority date
Expiry dateMar 23, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Thienopyrimidines of the formula I and their physiologically acceptable salts,in whichR1, R2 and X have the meanings given in claim 1, inhibit phosphodiesterase V and can be employed for the treatment of illnesses of the cardiovascular system and for the treatment and/or therapy of impaired potency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.